Abstract:OBJECTIVE:This study sought to investigate the role of the long noncoding RNA MALAT1 in the prognosis of stage II/III colorectal cancer (CRC) patients.METHODS:The expression of MALAT1 was evaluated in cancer tissues from 146 stage II/III CRC patients undergoing radical resection and 23 paired normal colonic mucosa samples using quantitative real-time reverse transcriptase PCR. Differences in the expression of MALAT1 between 23 CRC and paired normal colonic mucosa samples were analysed with the Wilcoxon test. Relationships between the expression level of MALAT1, patient clinicopathological parameters and disease-free survival (DFS) and overall survival (OS) were analysed using the univariate Kaplan-Meier method and the multivariate COX regression model.RESULTS:The MALAT1 levels in cancerous tissues were 2.26 times higher than those measured in noncancerous tissues, and this difference was statistically significant (P = 0.0004). Based on their expression level of MALAT1, the patients were divided into a high MALAT1 expression group (n = 73) and a low expression group (n = 73). Patients with tumours harbouring higher expression of MALAT1 showed a significantly worse prognosis with a hazard ratio (HR) of 2.863 (95% CI, 1.659 to 4.943; P < 0.001) for DFS and 3.968 (95% CI, 1.665 to 9.456; P = 0.002) for OS. Furthermore, patients with perineural invasion demonstrated significantly worse DFS (HR = 3.459, 95% CI 2.008 to 5.957; P < 0.001) and OS (HR = 3.750, 95% CI 1.743 to 8.069; P = 0.001) than those without perineural invasion. Multivariate analyses indicated that MALAT1 expression and perineural invasion were two independent prognostic risk factors for patients with CRC.CONCLUSION:The expression of MALAT1 is upregulated in CRC tissues, and a higher expression level of MALAT1 might serve as a negative prognostic marker in stage II/III CRC patients.

Long Non-Coding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 Regulates Renal Cancer Cell Migration Via Cofilin-1.

Malat1-Mediated Tumorigenesis

Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma

Inhibition of Metastasis-Associated Lung Adenocarcinoma Transcript 1 in CaSki Human Cervical Cancer Cells Suppresses Cell Proliferation and Invasion.

LncRNA MALAT1 Functions As a Competing Endogenous RNA to Regulate ZEB2 Expression by Sponging Mir-200S in Clear Cell Kidney Carcinoma

Human MALAT-1 Long Non-Coding RNA is Overexpressed in Cervical Cancer Metastasis and Promotes Cell Proliferation, Invasion and Migration.

High Expression of Lncrna MALAT1 Suggests a Biomarker of Poor Prognosis in Colorectal Cancer.

Regulatory Networks of LncRNA MALAT-1 in Cancer

Reciprocal regulation of Hsa-miR-1 and long noncoding RNA MALAT1 promotes triple-negative breast cancer development

MALAT-1 Is a Key Regulator of Epithelial–Mesenchymal Transition in Cancer: A Potential Therapeutic Target for Metastasis

Long Noncoding Rna Malat1 Promotes Brain Metastasis by Inducing Epithelial-Mesenchymal Transition in Lung Cancer

Functions and regulatory mechanisms of metastasis-associated lung adenocarcinoma transcript 1.

Long noncoding RNA MALAT-1: A versatile regulator in cancer progression, metastasis, immunity, and therapeutic resistance

Inhibition of MALAT1 Reduces Tumor Growth and Metastasis and Promotes Drug Sensitivity in Colorectal Cancer

Down-regulation of MALAT1 Inhibits Cervical Cancer Cell Invasion and Metastasis by Inhibition of Epithelial-Mesenchymal Transition.

Long non-coding RNA MALAT-1 modulates metastatic potential of tongue squamous cell carcinomas partially through the regulation of small proline rich proteins

Research Progress on a Long Non-coding RNA MALAT1

Analysis of the Regulation of Metastasis-Associated Lung Adenocarcinoma Transcript 1 on the Biological Behavior of Breast Cancer

Inducing cell proliferation inhibition, apoptosis, and motility reduction by silencing long noncoding ribonucleic acid metastasis-associated lung adenocarcinoma transcript 1 in urothelial carcinoma of the bladder.

Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition

Long Noncoding RNA Metastasis‐associated Lung Adenocarcinoma Transcript 1 Cooperates with Enhancer of Zeste Homolog 2 to Promote Hepatocellular Carcinoma Development by Modulating the Microrna‐22/snail Family Transcriptional Repressor 1 Axis